SAM
OLMA icon

SEB Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

SEB Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Hold
339,461
– – 0.02% 498
2026
Q1 		$5.06M Buy
+339,461
New +$7.56M 0.02% 452

Other funds holding OLMA

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SEB Asset Management's OLMA Position: Q2 2026 in Review

SEB Asset Management held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 339,461 shares worth $4.25M. The position accounts for 0.02% of the portfolio, ranked #498.

SEB Asset Management first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.06M in Q1 2026. 167 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • SEB Asset Management held 339,461 shares of Olema Pharmaceuticals worth $4.25M as of Q2 2026.
  • SEB Asset Management left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up 0.02% of SEB Asset Management's portfolio in Q2 2026, its #498 holding.
  • SEB Asset Management first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Olema Pharmaceuticals position peaked at $5.06M in Q1 2026.
  • 167 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.